Kazia Therapeutics (KZIA) Enterprise Value (2009 - 2025)
Kazia Therapeutics (KZIA) posted Enterprise Value of -$45.6 million for Q4 2025, down 1539.03% on a QoQ basis from -$2.8 million in Q2 2025, and down 2175.82% year-over-year from $2.2 million in Q4 2024.
Kazia Therapeutics (KZIA) has 14 years of Enterprise Value data on file, last reported at -$45.6 million in Q4 2025.
- In Q4 2025, Enterprise Value fell 2175.82% year-over-year to -$45.6 million; the TTM figure through Dec 2025 stood at -$45.6 million (down 2175.82% YoY), while the FY2025 annual figure was -$2.8 million, down 154.81% from the prior year.
- Enterprise Value declined to -$45.6 million in Q4 2025, from -$2.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.1 million in Q2 2024 and bottomed at -$45.6 million in Q4 2025.
- A 5-year average of -$9.6 million and a median of -$2.9 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 75.18% — and 2025, when it slumped 2175.82%.
- Year by year, Enterprise Value stood at -$21.2 million in 2021, then surged by 86.42% to -$2.9 million in 2022, then grew by 19.6% to -$2.3 million in 2023, then rose by 13.59% to -$2.0 million in 2024, then slumped by 2175.82% to -$45.6 million in 2025.
- The last three Enterprise Value figures came in at -$45.6 million (Q4 2025), -$2.8 million (Q2 2025), and -$2.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | -45.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.61 Mn |
| Jun 30, 2025 | -2.78 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Jun 30, 2024 | -1.09 Mn |
| Dec 31, 2023 | -2.32 Mn |
| Jun 30, 2023 | -3.50 Mn |
| Dec 31, 2022 | -2.88 Mn |
| Jun 30, 2022 | -5.27 Mn |
| Jun 30, 2021 | -21.24 Mn |
| Dec 31, 2020 | -14.16 Mn |
| Jun 30, 2020 | -5.74 Mn |
| Dec 31, 2019 | -4.40 Mn |
| Jun 30, 2019 | -3.81 Mn |
| Dec 31, 2018 | -3.88 Mn |
| Jun 30, 2018 | -4.51 Mn |
| Jun 30, 2017 | -10.86 Mn |
| Dec 31, 2016 | -4.98 Mn |
| Jun 30, 2016 | -24.98 Mn |
| Jun 30, 2012 | -5.83 Mn |
| Dec 31, 2011 | -11.15 Mn |
| Jun 30, 2011 | -6.39 Mn |
| Dec 31, 2010 | -10.84 Mn |
| Jun 30, 2010 | -13.38 Mn |
| Dec 31, 2009 | -14.43 Mn |
| Jun 30, 2009 | -30.40 Mn |